Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.
Hoda M GebrilAravind AryasomayajulaMariana Reis Nogueira de LimaKathryn E UhrichPrabhas V MoghePublished in: Translational neurodegeneration (2024)
The AM-NP nanotechnology presents a multifactorial strategy to target pathological Aβ aggregation and arrest the fAβ-mediated pathological progression in microglia and neurons.